Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
GDUFA IV: ‘Potential OAI’ Classification Could Mean User Fee Goal Extension
Dec 22 2025
•
By
Derrick Gingery
The pOAI goal date extension is intended to facilitate more first-cycle approvals.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from User Fees
More from United States